drugset / Trial / NCT07552246
Comparing Acupuncture With Medication to Reduce Anxiety and Depression in China
Phase 4
Not yet recruiting
120 enrolled
Duke Kunshan University
Kunshan Hospital of Traditional Chinese Medicine · collabKunshan Mental Health Center · collabNational Natural Science Foundation of China · collab
Non-randomizedParallel-groupSingle-blindTreatment
Summary
The main objective of this study is to compare medication (usual care) with acupuncture (as a standalone comparator) to identify the most (cost)effective and environmentally sustainable intervention to reduce anxiety and mild to moderate depression in adults in China.
Timeline
- Start
- 2026-04-01
- Primary completion
- 2027-03-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sertraline | Small molecule | 50 mg | — |
| Subject | Sertraline | Small molecule | 200 mg | — |
| Subject | Toludesvenlafaxine | Small molecule | 40 mg | — |
| Subject | Toludesvenlafaxine | Small molecule | 80 mg | — |
| Background | Alprazolam | Small molecule | 0.4 mg | — |
| Background | Alprazolam | Small molecule | 0.8 mg | — |
| Background | Lorazepam | Small molecule | 0.4 mg | — |
| Background | Lorazepam | Small molecule | 0.8 mg | — |